Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
Primary Cutaneous Acral CD8-Positive T-Cell Lymphoma
Tianjin, Tianjin Municipality
Primary Cutaneous Acral CD8-Positive T-Cell Lymphoma Clinical Trials in Tianjin, Tianjin Municipality
1 recruiting
Tianjin, Tianjin Municipality, China
Showing
1–1
of
1
trials
Recruiting
Phase 2
JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas
Lymphoma, T-Cell
T-LGL Leukemia
NK-LGL Leukemia
+7 more
Institute of Hematology & Blood Diseases Hospital, China
48 enrolled
2 locations
NCT06716658
Feedback